Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Factor Xiii Deficiency in Iran: A Comprehensive Review of the Literature Publisher Pubmed



Dorgalaleh A1 ; Naderi M2 ; Hosseini MS1 ; Alizadeh S1 ; Hosseini S3 ; Tabibian S1 ; Eshghi P4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Hematology, Allied Medical School, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Pediatrics Hematology and Oncology, Ali Ebn-e Abitaleb Hospital Research Center for Children and Adolescents Health, Zahedan University of Medical Sciences, Zahedan, IR, Iran
  3. 3. Departments of Hematology, Allied Medical School, Iran University of Medical Sciences, Tehran, Iran
  4. 4. Pediatric Congenital Hematologic Disorders Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Source: Seminars in Thrombosis and Hemostasis Published:2015


Abstract

Factor XIII deficiency (FXIIID) is a rare bleeding disorder with an estimated prevalence of 1 in 2-million population worldwide. In Iran, a Middle Eastern country with a high rate of consanguineous marriages, there are approximately 473 patients afflicted with FXIIID. An approximately 12-fold higher prevalence of FXIIID is estimated in Iran in comparison with overall worldwide frequency. In this study, we have undertaken a comprehensive review on different aspects of FXIIID in the Iranian population. The distribution of this disease in different regions of Iran reveals that Sistan and Baluchestan Province has not only the highest number of patients with FXIIID in Iran but the highest global incidence of this condition. Among Iranian patients, umbilical cord bleeding, hematoma, and prolonged wound bleeding are the most frequent clinical manifestations. There are several disease causing mutations in Iranian patients with FXIIID, with Trp187Arg being the most common mutation in FXIIID in Iran. Traditionally, the management of FXIIID in Iran was only based on administration of fresh frozen plasma or cryoprecipitate, until 2009 when FXIII concentrate became available for patient management. Various studies have evaluated the efficacy and safety of prophylactic regimens in different situations with valuable findings. Although the focus of this study is on Iran, it offers considerable insight into FXIIID, which can be applied more extensively to improve the management and quality of life in all affected patients. © 2015 by Thieme Medical Publishers, Inc.
Related Docs
View other Related Docs
1. Diagnosis of Factor Xiii Deficiency, Hematology (2016)
2. First Cases of Severe Congenital Factor Xiii Deficiency in Southwestern Afghanistan in the Vicinity of Southeast of Iran, Blood Coagulation and Fibrinolysis (2015)
3. Relationship Between the Matrix Metalloproteinases and the Occurrence of Central Nervous System Bleeding in Factor Xiii Deficiency, Journal of Isfahan Medical School (2015)
4. Association Between Expression of Mmp-2 and Mmp-9 Genes and Pathogenesis of Intracranial Hemorrhage in Severe Coagulation Factor Xiii Deficiency, Hematology (United Kingdom) (2015)
5. Central Nervous System Bleeding in Pediatric Patients With Factor Xiii Deficiency: A Study on 23 New Cases, Hematology (2015)
6. Coagulation Factor Xiii-A A614t Gene Variation Is Suggestive of Founder Effect in Iranian Patients With Sever Congenital Factor Xiii Deficiency, Journal of Cellular and Molecular Anesthesia (2016)
7. Diagnosis, Clinical Manifestations and Management of Rare Bleeding Disorders in Iran, Hematology (2017)
8. Effect of Social Factors on the Highest Global Incidence of Congenital Factor Xiii Deficiency in Southeast of Iran, Archives of Iranian Medicine (2015)
Experts (# of related papers)
View all Related Experts
Shaban Alizadeh (9)
Zahra Kashanikhatib (2)
Other Related Docs
9. Laboratory Diagnosis of Factor Xiii Deficiency, Routine Coagulation Tests With Quantitative and Qualitative Methods, Clinical Laboratory (2016)
10. Spectrum of Factor X Gene Mutations in Iranian Patients With Congenital Factor X Deficiency, Blood Coagulation and Fibrinolysis (2016)
11. Bleeding Episodes Among Patients With Congenital Fibrinogen Disorders, a Study on 12 New Iranian Patients, Journal of Cellular and Molecular Anesthesia (2018)
12. Establishment of a Prenatal Diagnosis Schedule As Part of a Prophylaxis Program of Factor Xiii Deficiency in the Southeast of Iran, Blood Coagulation and Fibrinolysis (2016)
13. Risk and Management of Intracerebral Hemorrhage in Patients With Bleeding Disorders, Seminars in Thrombosis and Hemostasis (2022)
14. Congenital Factor Ii Deficiency, Congenital Bleeding Disorders: Diagnosis and Management (2018)
15. Subarachnoid Hemorrhage in Congenital Factor X Deficiency: A Case Study and Literature Review, Iranian Red Crescent Medical Journal (2016)